KRRYNNE VINCENT: Open Payments
NPI 1841906138 · PLATTSBURGH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$681 in 35 payments from 12 companies in 2025. Trend: 2023 $547 · 2024 $734 · 2025 $681
Food & beverage: $681
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $188 |
| ANI Pharmaceuticals, Inc. | 5 | $89 |
| AKEBIA THERAPEUTICS INC | 3 | $88 |
| Novartis Pharmaceuticals Corporation | 4 | $85 |
| Travere Therapeutics, Inc. | 3 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
| SCPHARMACEUTICALS INC. | 2 | $41 |
| Renalytix AI, Inc. | 1 | $21 |
| Calliditas Therapeutics US Inc. | 1 | $20 |
| Vifor Pharma, Inc. | 1 | $17 |
Products named: KRYSTEXXA, PURIFIED CORTROPHIN GEL, Vafseo, JARDIANCE, Fabhalta, FUROSCIX, TAVNEOS, Filspari.
Industry payments across NY — which companies pay providers there.
